| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Acasti Pharma Inc. | Director | Common Shares | 792 | $1,464 | $1.85 | 31 Aug 2023 | Ofra Aslan (Spouse) |
| Acasti Pharma Inc. | Director | Common Shares | 381 | $704 | $1.85 | 31 Aug 2023 | Direct |
| Acasti Pharma Inc. | Director | Stock Options (Right to Buy) | 12,500 | 14 Jul 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GRCE | Acasti Pharma Inc. | 31 Aug 2023 | 1 | +$781 | 4 | Director | 05 Sep 2023, 16:54 |
| GRCE | Acasti Pharma Inc. | 14 Jul 2023 | 1 | $0 | 4 | Director | 18 Jul 2023, 16:36 |
| GRCE | Acasti Pharma Inc. | 28 Sep 2022 | 1 | $0 | 4 | Director | 30 Sep 2022, 16:20 |
| GRCE | Acasti Pharma Inc. | 12 Nov 2021 | 1 | $0 | 4 | Director | 16 Nov 2021, 15:21 |